BIB_156
NCT03860883 MelMarT-II — Melanoma Margins Trial-II. Sponsor: Melanoma & Skin Cancer Trials Ltd. 1 cm vs 2 cm WLE margin for Stage II primary cutaneous melanoma. 20 UK + 3 IRL sites recruiting 2026. [Tasks: 16, 03] Tier: 1 (RCT) Grade: A (in progress) Retrieved: 2026-05-07
- Evidence grade
- A
- Tier
- 1 (RCT)
- Cited by tasks
- 16, 03
- Identifiers
- —
Full extracted findings & patient-implication analysis: bibliography/BIB_156/findings.md (research corpus). This page is a short context summary — not individualised medical advice.